Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay

被引:104
作者
Turpeinen, M
Jouko, U
Jorma, J
Olavi, P
机构
[1] Oulu Univ, Dept Pharmacol & Toxicol, Oulu, Finland
[2] Oulu Univ, Dept Chem, Oulu, Finland
[3] Current Affiliate Novamass Analyt Ltd, Oulu, Finland
关键词
cytochrome P450; CYP; in vitro cocktail; inhibition; LC/MS; human liver microsomes; HUMAN LIVER-MICROSOMES; CYTOCHROME-P450; ENZYMES; SELECTIVE INHIBITORS; METABOLISM; COCKTAIL; MIDAZOLAM; 2C9; SULFAPHENAZOLE; HYDROXYLASE; FLUVOXAMINE;
D O I
10.1016/j.ejps.2004.10.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The dramatically increased number of new chemical entities (NCE) used in drug discovery has raised a demand for efficient and rapid drug metabolism screening techniques. The aim of this study was to develop a global in vitro metabolic interaction screening test utilising the N-in-1 approach. A cocktail consisting of 10 CYP-selective probes with known kinetic, metabolic and interaction properties in vivo was incubated in a pool of human liver microsomes, and metabolites of melatonin (CYP1A2), coumarin (CYP2A6), bupropion (CYP2B6), amodiaquine (CYP2C8), toibutamide (CYP2C9), omeprazole (CYP2C19 and CYP3A4), dextromethorphan (CYP2D6), chlorzoxazone (CYP2E1), midazolam (CYP3A4) and testosterone (CYP3A4) were analysed simultaneously using LC/TOF-MS. Performance of the method was assessed with cDNA expressed P450s and diagnostic CYP-specific inhibitors. The results were in good accordance with literature and our previous studies. The cocktail developed is Suitable for fast and reliable in vitro screening of the interaction potential and characteristics of NCEs. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:123 / 132
页数:10
相关论文
共 35 条
[1]   KETOCONAZOLE AND SULFAPHENAZOLE AS THE RESPECTIVE SELECTIVE INHIBITORS OF P4503A AND 2C9 [J].
BALDWIN, SJ ;
BLOOMER, JC ;
SMITH, GJ ;
AYRTON, AD ;
CLARKE, SE ;
CHENERY, RJ .
XENOBIOTICA, 1995, 25 (03) :261-270
[2]   EFFECTS OF DISULFIRAM ON HEPATIC P450IIE1, OTHER MICROSOMAL-ENZYMES, AND HEPATOTOXICITY IN RATS [J].
BRADY, JF ;
XIAO, F ;
WANG, MH ;
LI, Y ;
NING, SM ;
GAPAC, JM ;
YANG, CS .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 108 (02) :366-373
[3]   EFFECT OF QUINIDINE ON THE DEXTROMETHORPHAN O-DEMETHYLASE ACTIVITY OF MICROSOMAL FRACTIONS FROM HUMAN-LIVER [J].
BROLY, F ;
LIBERSA, C ;
LHERMITTE, M ;
BECHTEL, P ;
DUPUIS, B .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (01) :29-36
[4]   FLUVOXAMINE IS A POTENT INHIBITOR OF CYTOCHROME-P4501A2 [J].
BROSEN, K ;
SKJELBO, E ;
RASMUSSEN, BB ;
POULSEN, HE ;
LOFT, S .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (06) :1211-1214
[5]   High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1 [J].
Bu, HZ ;
Magis, L ;
Knuth, K ;
Teitelbaum, P .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2001, 15 (10) :741-748
[6]   The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes [J].
Christensen, M ;
Andersson, K ;
Dalén, P ;
Mirghani, RA ;
Muirhead, GJ ;
Nordmark, A ;
Tybring, G ;
Wahlberg, A ;
Yasar, Ü ;
Bertilsson, L .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (06) :517-528
[7]  
Dierks EA, 2001, DRUG METAB DISPOS, V29, P23
[8]  
Ekins S, 1998, J PHARMACOL EXP THER, V286, P1253
[9]   Validation of the five-drug ''Pittsburgh cocktail'' approach for assessment of selective regulation of drug-metabolizing enzymes [J].
Frye, RF ;
Matzke, GR ;
Adedoyin, A ;
Porter, JA ;
Branch, RA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (04) :365-376
[10]   OXIDATION OF TOXIC AND CARCINOGENIC CHEMICALS BY HUMAN CYTOCHROME-P-450 ENZYMES [J].
GUENGERICH, FP ;
SHIMADA, T .
CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (04) :391-407